SUZANNE RACZ: Open Payments
NPI 1629302542 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,669 in 41 payments from 2 companies in 2025. Trend: 2023 $10,141 · 2024 $4,922 · 2025 $12,669
Speaker / faculty: $10,650Travel & lodging: $1,753Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 40 | $12,651 |
| ABBVIE INC. | 1 | $19 |
Products named: Fintepla, Nayzilam, Briviact, QULIPTA.
Industry payments across TX — which companies pay providers there.
